Sildenafil Tablet, Film Coated
Product Images NDC 68071-3954
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-3954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
4 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 05)
This is a chart showing the change from baseline in meters at different time points during a study. The study involves three groups taking different doses of a medication (Placebo, Sildenafil 20mg TID, Sildenafil 40mg TID, Sildenafil 80mg TID) over a 12-week period. The chart provides the changes in distance covered for each group at each week of the study.*
5 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 06)
The text provides data related to a clinical trial involving the use of Sildenafil 20 mg TID as a placebo for patients with Idiopathic Pulmonary Arterial Hypertension (PAH). The information includes details such as baseline walk distance, PAH etiology, PH criteria, functional capacity, gender distribution, age distribution, and changes in 6-minute walk distance. This data can be valuable for understanding the effects and outcomes of Sildenafil in the treatment of PAH.*
Pi Logo (55aa9711 6df5 4516 Bf00 A1acf7f7a464 09)
Logo (55aa9711 6df5 4516 Bf00 A1acf7f7a464 10)
Pdp (68071 3954 9)
This is a medication label for Sildenafil 20mg tablets. It includes details such as the lot number, manufacturer NDC, expiration date, and serial number. The label also provides information on reporting side effects and contacting a doctor for medical advice. It ends with a warning to keep the medication out of reach of children and store it at a controlled temperature of 68-77°F.*
Figure-1 (Figure 1)
This text contains information about drug interactions and recommendations related to fold change, 90% confidence interval, and dose adjustments for various medications such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Oral Contraceptives, Ritonavir, and Saquinavir. It also mentions guidelines for coadministration and potential lack of benefit in exercise capacity when combining sildenafil with bosentan therapy.*
Figure-2 (Figure 2)
Figure-5 (Figure 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.